Sorrento And Mount Sinai To Jointly Develop COVI-SHIELD Antibody Therapy Targeting SARS-CoV-2 Infection (COVID-19) Read more
Novartis announces plan to initiate clinical trial of canakinumab for patients with COVID-19 pneumonia Read more
Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19 Read more
Novartis Kymriah receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma Read more
Gilead, Kite and oNKo-innate Announce Research Collaboration to Discover Cancer Immunotherapies Focused on NK Cells Read more
Intensity Therapeutics Signs Clinical Collaboration Agreement with BMS for Advanced Solid Tumors Read more